Vallejo, United States
Biosimilar Solutions is a leading biotechnology startup specializing in the development and commercialization of high-quality therapeutics for regulated markets. With a strong emphasis on affordability and increased patient access, the company demonstrates a clear focus on maintaining uncompromising quality. Recognizing the unique challenges of biosimilar product development, Biosimilar Solutions has assembled a world-class team with extensive experience in biologic therapeutic development, including industry veterans from pioneering companies such as Amgen and Genentech.
The company's team boasts significant contributions to numerous Investigational New Drug applications and marketing applications, including those for Enbrel, the originator product for Biosimilar Solutions' lead biosimilar product candidate. Additionally, Biosimilar Solutions has established a distinguished Scientific Advisory Board comprised of leading scientists within the field. The company was founded in 2019 and operates within the Health Care industry, demonstrating a strong potential for growth and innovation within the biopharmaceutical sector.
